Towards Healthcare
Tele-oncology Market Size Uptrends by 15.76% CAGR till 2034

Tele-oncology Market Size North America Leads, Asia Pacific to See Fastest CAGR Through 2034

Based on market forecasts, the global tele-oncology market, projected at USD 4.74 billion in 2024, is expected to reach USD 20.48 billion by 2034, growing at a CAGR of 15.76% over the forecast period. A sure sign of the adoption of advanced healthcare technologies and wearable devices is the propelling global market expansion. However, North America dominated due to the accelerating adoption of virtual healthcare platforms.

  • Insight Code: 5989
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The tele-oncology market in 2025 is valued at USD 5.49 billion and is projected to climb to USD 20.48 billion by 2034, with a CAGR of 15.76% over the forecast period.

North America is currently leading the tele-oncology market due to the increasing adoption of virtual healthcare platforms and remote patient monitoring technologies.

The tele-oncology market includes 4 segments such as by component, by application, by cancer type, and by region.

Some key players include Teladoc Health, Amwell, GE Healthcare, Philips Healthcare, and Siemens Healthineers.

The different types of telepathology include static (store-and-forward), dynamic, and hybrid.

MoHFW, NIH, US FDA, CDC, NCI, VA.GOV, HHS, EHOSPITAL, GOV.UK